« Previous
Next »
Gastroenterology
Volume 142, Issue 2
, Pages 248-256
, February 2012
Next-Generation Stool DNA Test Accurately Detects Colorectal Cancer and Large Adenomas
To access this article, please choose from the options below
This article has an accompanying continuing medical education activity on page e25. Learning Objective: Upon completion of this CME activity, successful learners will be able to appraise the early clinical performance of a next-generation stool DNA test for detection of colorectal cancer and large adenomas.
Conflicts of interest These authors disclose the following: Dr Ahlquist and Mr Taylor are inventors of licensed technology. Drs Ahlquist and Vogelstein are scientific advisors to Exact Sciences. Drs Zou, Domanico, Berger, and Lidgard are employees of Exact Sciences. Mayo Clinic has licensed intellectual property to and is a minor equity investor in Exact Sciences. The remaining authors disclose no conflicts.
Funding Exact Sciences Corporation, National Institutes of Health grant CA 62924, and grants from Charles Oswald Foundation and Virginia and D.K. Ludwig Fund for Cancer Research.
PII: S0016-5085(11)01505-8
doi: 10.1053/j.gastro.2011.10.031
© 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Gastroenterology
Volume 142, Issue 2
, Pages 248-256
, February 2012

